Compare Nuwellis Inc (NUWE) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Open Text Corporation — how do they compare? Nuwellis Inc trades at $0.7 (market cap $2.20M), while Open Text Corporation trades at $23.36 (market cap $5.61B). The key difference: Open Text Corporation is far larger — about 2550× Nuwellis Inc's market cap, and Open Text Corporation pays a 4.82% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Open Text Corporation for 23 Days on average.
| NUWE | OTEX | |
|---|---|---|
Market Cap | $2.20M | $5.61B |
Volume | 121,544 | 1,197,475 |
Sector | Health | Technology |
52-Week High | $146.65 | $39.69 |
52-Week Low | $0.68 | $20.01 |
Typical Hold Time | 26 Days | 23 Days |
Enterprise Value | -$1.52M | $10.63B |
Dividend Yield | — | 4.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
OpenText (OTEX) trades at $23.14, up 1.89% today, with strong technical momentum indicated by a bullish overall signal. The company demonstrates robust fundamentals with consistent earnings beats, posting Q2 2026 EPS of $1.23 versus $1.02 expected, and maintains healthy profitability with 12.26% net income margin. Recent corporate actions include a $1 billion senior secured notes offering and strategic AI partnerships, signaling growth initiatives.
The stock presents an attractive valuation opportunity with P/E of 9.01 and P/S of 1.1 below sector averages, supported by analyst consensus target of $28.30 implying 22% upside. Key risks include high debt levels at $6.34 billion and competitive pressures in the software sector. Institutional sentiment remains mixed with 42% buy ratings amid ongoing debt management efforts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
